NIH chief laments demise of US biomedical edge
This article was originally published in Scrip
Executive Summary
The slide in funding for US biomedical research and development is not a favorite topic, by any means, for Dr Francis Collins, director of the National Institutes of Health (NIH). But it is a subject for which he frequently finds himself engaged in explaining.